Published in Stroke on July 14, 2011
Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome. Neurology (2015) 1.60
Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage. Neurology (2015) 1.45
Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome. Ann Neurol (2014) 1.06
Relationship between C-reactive protein and stroke: a large prospective community based study. PLoS One (2014) 0.92
Heart rate variability for preclinical detection of secondary complications after subarachnoid hemorrhage. Neurocrit Care (2014) 0.83
Free Fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage. Stroke (2012) 0.81
Biomarkers as outcome predictors in subarachnoid hemorrhage--a systematic review. Biomarkers (2014) 0.80
Toll-like Receptor 4 (TLR4) is Associated with Cerebral Vasospasm and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage. Neurol Med Chir (Tokyo) (2015) 0.80
IN VITRO QUANTIFICATION OF THE SIZE DISTRIBUTION OF INTRASACCULAR VOIDS LEFT AFTER ENDOVASCULAR COILING OF CEREBRAL ANEURYSMS. Cardiovasc Eng Technol (2013) 0.78
Current Advances in the Use of Therapeutic Hypothermia. Ther Hypothermia Temp Manag (2013) 0.75
Causal Structure of Brain Physiology after Brain Injury from Subarachnoid Hemorrhage. PLoS One (2016) 0.75
Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11
Bioethical considerations in translational research: primate stroke. Am J Bioeth (2009) 7.21
Guidelines for the evaluation and management of status epilepticus. Neurocrit Care (2012) 5.00
Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation (2005) 4.08
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome. Stroke (2002) 3.36
Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol (2002) 3.36
National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24
Clinical trial of a novel surface cooling system for fever control in neurocritical care patients. Crit Care Med (2004) 3.24
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol (2011) 3.08
Continuous electroencephalography in the medical intensive care unit. Crit Care Med (2009) 2.86
Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke (2011) 2.81
Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care (2011) 2.81
Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med (2006) 2.58
Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage. Neurosurgery (2009) 2.58
Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med (2008) 2.57
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging (2013) 2.56
Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke (2005) 2.49
Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and hispanics: the northern Manhattan study. Circulation (2012) 2.48
Current status of endovascular stroke treatment. Circulation (2011) 2.42
Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke (2005) 2.36
Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity (2006) 2.36
Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke (2013) 2.34
Neuropsychological dysfunction in the absence of structural evidence for cerebral ischemia after uncomplicated carotid endarterectomy. Neurosurgery (2006) 2.33
Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke (2009) 2.33
Risk of myocardial infarction or vascular death after first ischemic stroke: the Northern Manhattan Study. Stroke (2007) 2.30
Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke (2009) 2.28
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology (2013) 2.26
ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci (2002) 2.25
NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline. NIH Consens State Sci Statements (2010) 2.19
Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17
External ventricular drainage following aneurysmal subarachnoid haemorrhage. Br J Neurosurg (2010) 2.15
Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia (2002) 2.14
Predictors of cognitive dysfunction after subarachnoid hemorrhage. Stroke (2002) 2.13
Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13
Intracranial infectious aneurysms: a comprehensive review. Neurosurg Rev (2009) 2.11
Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children. Arch Neurol (2006) 2.05
Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol (2010) 2.00
Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med (2007) 1.97
Experimental treatments for acute ischaemic stroke. Lancet (2007) 1.97
Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail (2014) 1.96
A controlled prospective study of neuropsychological dysfunction following carotid endarterectomy. Arch Neurol (2002) 1.91
Stroke location and association with fatal cardiac outcomes: Northern Manhattan Study (NOMAS). Stroke (2008) 1.91
Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study. Am J Clin Nutr (2011) 1.91
Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke (2007) 1.90
Prognostic significance of continuous EEG monitoring in patients with poor-grade subarachnoid hemorrhage. Neurocrit Care (2006) 1.89
Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage. Circulation (2005) 1.88
Risk factors and preventive interventions for Alzheimer disease: state of the science. Arch Neurol (2011) 1.85
Ventriculostomy-related infections: a critical review of the literature. Neurosurgery (2002) 1.84
Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest (2002) 1.80
Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke (2003) 1.78
Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation (2008) 1.77
Infectious burden and cognitive function: the Northern Manhattan Study. Neurology (2013) 1.77
Carotid-cavernous fistulas. Neurosurg Focus (2012) 1.76
Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med (2004) 1.76
Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol (2009) 1.74
Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS). Diabetes Care (2008) 1.69
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neurosurgery (2006) 1.68
Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc (2007) 1.66
Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke (2012) 1.65
Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery (2006) 1.65
Metabolic benefits of surface counter warming during therapeutic temperature modulation. Crit Care Med (2009) 1.64
Generalized periodic discharges in the critically ill: a case-control study of 200 patients. Neurology (2012) 1.64
Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res (2006) 1.63
Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study. Circulation (2013) 1.61